What is the success rate of stem cell therapy for Back Pain & Disc Degeneration?
No general regenerative success rate exists for back pain. Different diagnoses and high spontaneous variability make uncontrolled before-and-after results unreliable. Review randomisation, comparator, validated pain and disability measures, medication use, return to activity, adverse events and duration.
What the evidence shows for Back Pain & Disc Degeneration
Before research is considered, identify red flags and the anatomical diagnosis; imaging findings alone may not explain symptoms. Product studies must match source, processing, dose, route, comparator, diagnosis and validated pain and function outcomes. The FDA consumer alert states that the promoted regenerative products it addresses have not been approved in the United States for disc disease or back pain.
Am I a candidate? → · Back Pain & Disc Degeneration: full overview → · Back Pain & Disc Degeneration cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Back Pain & Disc Degeneration: cell-therapy evidence and registered trials
- How much does stem cell therapy for Back Pain & Disc Degeneration cost? (2026)
- Back Pain & Disc Degeneration stem cell therapy — your questions answered (2026)
- Back Pain & Disc Degeneration: cell-therapy evidence by therapy class